Medicare GLP-1 Discount Program Excludes Certain Patients

A new report indicates Medicare's 18-month pilot program, offering GLP-1 medications at a $50 monthly discount, is denying access to some patients with specific diagnoses like severe obstructive sleep apnea. This raises concerns about equitable access to these popular weight-loss drugs for individuals with multiple health conditions, potentially limiting the program's reach for those most in need.